Found: 27
Select item for more details and to access through your institution.
Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy: Breaking a dangerous bond.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 11/12, p. 478, doi. 10.1007/s00508-022-02012-3
- By:
- Publication type:
- Article
Austrian recommendations for the management of essential thrombocythemia.
- Published in:
- Wiener Klinische Wochenschrift, 2021, v. 133, n. 1/2, p. 52, doi. 10.1007/s00508-020-01761-3
- By:
- Publication type:
- Article
Correction to: Ruxolitinib therapy formyelofibrosis in Austria.
- Published in:
- Wiener Klinische Wochenschrift, 2019, v. 131, n. 1/2, p. 47, doi. 10.1007/s00508-018-1428-7
- By:
- Publication type:
- Article
Ruxolitinib therapy for myelofibrosis in Austria.
- Published in:
- Wiener Klinische Wochenschrift, 2018, v. 130, n. 17/18, p. 495, doi. 10.1007/s00508-018-1365-5
- By:
- Publication type:
- Article
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant‐ineligible patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 1008, doi. 10.1002/ajh.27280
- By:
- Publication type:
- Article
Phenotypic characterization of disease‐initiating stem cells in JAK2‐ or CALR‐mutated myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. 770, doi. 10.1002/ajh.26889
- By:
- Publication type:
- Article
PD‐L1 overexpression correlates with JAK2‐V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 390, doi. 10.1002/ajh.26461
- By:
- Publication type:
- Article
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. 885, doi. 10.1002/ajh.24788
- By:
- Publication type:
- Article
Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 58, doi. 10.1111/ejh.13516
- By:
- Publication type:
- Article
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 2, p. 131, doi. 10.1111/ejh.13070
- By:
- Publication type:
- Article
Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e284, doi. 10.1016/j.clml.2019.09.468
- By:
- Publication type:
- Article
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Bisphosphonat-assoziierte Osteonekrosen des Kieferknochens.
- Published in:
- Wiener Klinische Wochenschrift, 2008, v. 120, n. 15/16, p. 467, doi. 10.1007/s00508-008-1002-9
- By:
- Publication type:
- Article
Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab
- Published in:
- Molecular Oncology, 2010, v. 4, n. 2, p. 150, doi. 10.1016/j.molonc.2010.01.002
- By:
- Publication type:
- Article
Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 1, p. 205, doi. 10.1007/s00432-020-03323-6
- By:
- Publication type:
- Article
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross‐sectional analysis of the randomized AGMT 02 study.
- Published in:
- EJHaem, 2024, v. 5, n. 3, p. 494, doi. 10.1002/jha2.925
- By:
- Publication type:
- Article
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 1, p. 73, doi. 10.1111/j.1600-0609.2005.00423.x
- By:
- Publication type:
- Article
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 6, p. 822, doi. 10.1111/bjh.12710
- By:
- Publication type:
- Article
Characterization of Folded Recombinant Der p 5, a Potential Diagnostic Marker Allergen for House Dust Mite Allergy.
- Published in:
- International Archives of Allergy & Immunology, 2008, v. 147, n. 2, p. 101, doi. 10.1159/000135696
- By:
- Publication type:
- Article
Cell Surface Membrane Antigen Phenotype of Human Gastrointestinal Mast Cells.
- Published in:
- International Archives of Allergy & Immunology, 2005, v. 138, n. 2, p. 111, doi. 10.1159/000088432
- By:
- Publication type:
- Article
Indolent Systemic Mastocytosis with Elevated Serum Tryptase, Absence of Skin Lesions, and Recurrent Severe Anaphylactoid Episodes.
- Published in:
- International Archives of Allergy & Immunology, 2005, v. 136, n. 3, p. 273, doi. 10.1159/000083954
- By:
- Publication type:
- Article
Attrition Rates in Multiple Myeloma Treatment under Real World Conditions—An Analysis from the Austrian Myeloma Registry (AMR).
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 962, doi. 10.3390/cancers15030962
- By:
- Publication type:
- Article
Stratification for RRMM and Risk-Adapted Therapy: Sequencing of Therapies in RRMM.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5886, doi. 10.3390/cancers13235886
- By:
- Publication type:
- Article
The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4701, doi. 10.3390/cancers13184701
- By:
- Publication type:
- Article
Pathway-Directed Therapy in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1668, doi. 10.3390/cancers13071668
- By:
- Publication type:
- Article
Allergen cleavage by effector cell-derived proteases regulates allergic inflammation.
- Published in:
- FASEB Journal, 2006, v. 20, n. 7, p. 967, doi. 10.1096/fj.05-3999fje
- By:
- Publication type:
- Article
Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth-inhibitory and VEGF-suppressive effects of rapamycin in leukemic cells.
- Published in:
- FASEB Journal, 2005, v. 19, n. 8, p. 960, doi. 10.1096/fj.04-1973fje
- By:
- Publication type:
- Article